Katia Bravo-Jaimes

Katia Bravo-Jaimes

Auto-generated profile, based on publicly available information

Katia Bravo-Jaimes

Department of Cardiovascular Medicine, Mayo Clinic Florida, Jacksonville, Florida, USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 April 2023 in Journal of the American Heart Association
Verified
Journal Article
Open access
GVGladys R. R Velarde
Gladys R. R Velarde
KBKatia Bravo‐Jaimes
Katia Bravo‐Jaimes
EBEric Brandt
Eric Brandt
DWDaniel Wang
Daniel Wang
PDPaul Douglass
Paul Douglass
KWKarol Watson
Karol Watson
Racial disparities in cardiovascular disease are unjust, systematic, and preventable. Social determinants are a primary cause of health disparities, and these include factors such as structural and overt racism. Despite a number of efforts implemented over the past several decades, disparities in cardiovascular disease care and outcomes persist, pervading more the outpatient rather than the inpatient setting, thus putting racial and ethnic minority groups at risk for hospital readmissions. In this article, we discuss differences in care and outcomes of racial and ethnic minority groups in both of these settings through a review of registries. Furthermore, we explore potential factors that connote a revolving door phenomenon for those whose adverse outpatient environment puts them at risk for hospital readmissions. Additionally, we review promising strategies, as well as actionable items at the policy, clinical, and educational levels aimed at locking this revolving door.

Verified
Journal Article
Open access
PDF file
KLKeila N Lopez
Keila N Lopez
KAKiona Y. Allen
Kiona Y. Allen
CBCarissa Marrie Baker-Smith
Carissa Marrie Baker-Smith
KBKatia Bravo-Jaimes
Katia Bravo-Jaimes
JBJoseph Burns
Joseph Burns
DADeidra A. Ansah
Deidra A. Ansah
Achieving health equity in populations with congenital heart disease (CHD) requires recognizing existing disparities throughout the lifespan that negatively and disproportionately impact specific groups of individuals. These disparities occur at individual, institutional, or system levels and often result in increased morbidity and mortality for marginalized or racially minoritized populations (population subgroups (e.g., ethnic, racial, social, religious) with differential power compared to those deemed to hold the majority power in the population). Creating actionable strategies and solutions to address these health disparities in patients with CHD requires critically examining multilevel factors and health policies that continue to drive health inequities, including varying social determinants of health (SDOH), systemic inequities, and structural racism. In this comprehensive review article, we focus on health equity solutions and health policy considerations for minoritized and marginalized populations with CHD throughout their lifespan in the United States. We review unique challenges that these populations may face and strategies for mitigating disparities in lifelong CHD care. We assess ways to deliver culturally competent CHD care and to help lower-health-literacy populations navigate CHD care. Finally, we review system-level health policies that impact reimbursement and research funding, as well as institutional policies that impact leadership diversity and representation in the workforce.

3 December 2021 in American Journal of Transplantation
Verified
Journal Article
Open access
PDF file
KBKatia Bravo-Jaimes
Katia Bravo-Jaimes
KAKelly Axsom
Kelly Axsom
JMJonathan Menachem
Jonathan Menachem
DDDavid Danford
David Danford
SKShelby Kutty
Shelby Kutty
ACAri Cedars
Ari Cedars
Adults with congenital heart disease (ACHD) experience worse waitlist outcomes and higher early post-transplant mortality compared to non-ACHD patients. On October 18, 2018; the UNOS donor heart allocation system was redesigned giving unique listing status to ACHD patients. The impact of this change on outcomes in transplant-listed patients is unstudied. Using the Scientific Registry of Transplant Recipients (SRTR) we compared ACHD patients listed for the first-time for heart transplantation from 2 eras of equal duration. We analyzed waitlist outcomes, post-transplant mortality and length of stay among ACHD patients in both eras and between ACHD and non-ACHD patients in the new era. Of 12723 listed patients, 535 had ACHD (293 in the new era) and 12188 did not (6258 in the new era). A total of 163 (56%) ACHD patients in the new era versus 150 (62%) in the prior era were transplanted; 11 (3.8%) versus 15 (6.2%) died on the waitlist; 32 (11%) versus 35 (14%) were delisted and 15 (9.2%) versus 19 (12.7%) died within 30 days of transplant respectively. The new UNOS donor heart allocation system improved waitlist outcomes among ACHD patients without altering early post-transplant outcomes or significantly changing the gap in outcomes compared to non-ACHD patients.

24 April 2022 in The American Journal of Cardiology
Verified
Journal Article
Closed access
KBKatia Bravo-Jaimes
Katia Bravo-Jaimes
MMMiluska Olenka Mejia
Miluska Olenka Mejia
NANadia Isabel Abelhad
Nadia Isabel Abelhad
YZYelin Zhou
Yelin Zhou
MJMarwan Faris Jumean
Marwan Faris Jumean
ADAbhijeet Dhoble
Abhijeet Dhoble

1 February 2021 in Nutrition, Metabolism and Cardiovascular Diseases
Verified
Journal Article
Closed access
GVGladys R. R Velarde
Gladys R. R Velarde
NCNaila Choudhary
Naila Choudhary
KBKatia Bravo-Jaimes
Katia Bravo-Jaimes
CSCarmen Smotherman
Carmen Smotherman
SSSaadia Sherazi
Saadia Sherazi
DKDale F. Kraemer
Dale F. Kraemer

27 December 2024 in Children
Verified
Journal Article
Open access
PDF file
DLDavid M. Leone
David M. Leone
DODonnchadh O’sullivan
Donnchadh O’sullivan
KBKatia Bravo-Jaimes
Katia Bravo-Jaimes
Artificial intelligence (AI) is revolutionizing healthcare by offering innovative solutions for diagnosis, treatment, and patient management. Only recently has the field of pediatric cardiology begun to explore the use of deep learning methods to analyze electrocardiogram (ECG) data, aiming to enhance diagnostic accuracy, expedite workflows, and improve patient outcomes. This review examines the current state of AI-enhanced ECG interpretation in pediatric cardiology applications, drawing insights from adult AI-ECG research given the progress in this field. It describes a broad range of AI methodologies, investigates the unique challenges inherent in pediatric ECG analysis, reviews the current state of the literature in pediatric AI-ECG, and discusses potential future directions for research and clinical practice. While AI-ECG applications have demonstrated considerable promise, widespread clinical adoption necessitates further research, rigorous validation, and careful consideration of equity, ethical, legal, and practical challenges.